A Study by Scintigraphy to Evaluate the Effect of Exenatide on Gastric Emptying in Subjects With Type 2 Diabetes
Status:
Completed
Trial end date:
2005-06-01
Target enrollment:
Participant gender:
Summary
As exenatide slows the rate at which materials leave the stomach, it is likely to alter the
rate of intestinal absorption of oral drugs when administered within a certain timeframe
relative to exenatide. In addition, the residence time within the stomach of other medication
may be prolonged and data from this study will help assess the change in residence time in
the presence of therapeutic doses of exenatide. This study will also evaluate the
relationship between blood levels of exenatide and parameters measuring rate of stomach
emptying.